Status: Not yet recruiting
Facial Vascularized Composite Allotransplantation: A Study Evaluating Safety, Functional Outcomes, and Patient-Reported Psychosocial Outcomes
The primary objective of this study is to evaluate the 5-year (60-month) allograft survival rate of facial vascularized composite allotransplantation performed under the standardized CONSORT clinical protocol.
Participants needed: 5
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Yale UniversityUpdated: Sep 9, 2026Locations: 9
Eligibility criteria
Competent to provide informed consent, as determined through structured clinical... [+26]
Anatomical or surgical factors that render transplantation unsafe or technically... [+25]